Skip to content

Biohaven BHVN Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Eli Lilly logo
Eli LillyLLY
$4.09B+78.5%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$3.25M
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$19.42M+31.1%
uniQure logo
uniQureQURE
$2.68M-57.8%
Roivant Sciences logo
Roivant SciencesROIV
$70K+218%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$229K-34.9%

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.23B-48.1%
Enterprise value$2.23B-46.3%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's other non-current liabilities?
Biohaven (BHVN) reported other non-current liabilities of $4.56M in Q1 2026.
How has Biohaven's other non-current liabilities changed year-over-year?
Biohaven's other non-current liabilities decreased by 1.2% year-over-year, from $4.61M to $4.56M.
What is the long-term trend for Biohaven's other non-current liabilities?
Over 4 years (2021 to 2025), Biohaven's other non-current liabilities has grown at a 14.8% compound annual growth rate (CAGR), from $2.64M to $4.58M.
What does other non-current liabilities mean?
Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.